Century Therapeutics, Inc. (IPSC) Institutional Ownership

Ownership Summary

Century Therapeutics, Inc. (NASDAQ:IPSC) appears in 45 institutional 13F filings for the quarter ending December 2025.

• Collectively, these holders controlled 29.6% of Century Therapeutics's outstanding shares in December 2025, up from 23.4% in September 2025.
• They increased total shares held in Century Therapeutics by 67.61% from the prior quarter, while the number of investors in IPSC decreased 37.5% year over year.
• During the quarter, 17 of these 45 funds increased positions in IPSC, 12 reduced exposure, and 16 held steady.
• Institutional investors collectively held 25.63Mn shares in Century Therapeutics as of December 2025, up by 10.34Mn shares quarter on quarter, and down 11.37Mn shares year over year.
• Point72 Asset Management, L.P. is the top holder of Century Therapeutics as of December 31, 2025, with 5.96Mn shares representing 6.89% of outstanding stock.
• Top purchasers of IPSC stock for the quarter ending December 2025 included Point72 Asset Management, L.P. (5.96Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.84Mn), Spruce Street Capital LP (1.42Mn), DAFNA Capital Management LLC (1.09Mn), TWO SIGMA INVESTMENTS, LP (584.47K).
• The biggest sellers of Century Therapeutics for the quarter ending December 2025 included RENAISSANCE TECHNOLOGIES LLC (1.24Mn), GSA CAPITAL PARTNERS LLP (270.28K), MILLENNIUM MANAGEMENT LLC (133.39K), FMR LLC (120.6K), CITADEL ADVISORS LLC (41.37K).
• Per Business Quant data, the top 10 holders of Century Therapeutics for the quarter ending December 2025 are Point72 Asset Management, L.P. (5.96Mn), DAFNA Capital Management LLC (2.79Mn), VANGUARD GROUP INC (2.1Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.84Mn), TWO SIGMA INVESTMENTS, LP (1.5Mn), Spruce Street Capital LP (1.42Mn), RENAISSANCE TECHNOLOGIES LLC (1.35Mn), TWO SIGMA ADVISERS, LP (1.27Mn), Casdin Capital, LLC (1.23Mn), ACADIAN ASSET MANAGEMENT LLC (1.22Mn).